Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Dsouza

Psychiatry Rockford, IL Medical Doctor

NPI 1962502781 CMS profile 88440

6072 Brynwood Dr Ste 205, Rockford, IL 61114

Open in the dashboard

General payments

$6,562

224 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anthony Dsouza of Rockford, IL is reported in the CMS Open Payments database as having received $6,562 across 224 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $61 3
2024 General $35 2
2023 General $104 6
2021 General $915 39
2020 General $1,027 52
2019 General $4,421 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Dsouza
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Anthony Dsouza were reported at $61. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Anthony Dsouza Psychiatry median Middle half National median
2019 $4,421 $184 $59–$605 $163
2020 $1,027 $119 $36–$372 $114
2021 $915 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $104 $170 $56–$651 $160
2024 $35 $179 $57–$673 $164
2025 $61 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $2,065 24 payments
  2. Otsuka America Pharmaceutical, Inc. $852 37 payments
  3. Alkermes, Inc. $389 7 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $374 18 payments
  5. Sunovion Pharmaceuticals Inc. $332 14 payments
  6. AbbVie, Inc. $286 15 payments
  7. Tris Pharma Inc $280 14 payments
  8. Janssen Pharmaceuticals, Inc $248 10 payments
  9. Teva Pharmaceuticals USA, Inc. $237 11 payments
  10. Jazz Pharmaceuticals Inc. $177 5 payments
  11. Other $1,322 69 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,544 215 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,625 1 payment
  3. Education $393 8 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR $2,026 26 payments
  2. ABILIFY MAINTENA $536 22 payments
  3. REXULTI $410 20 payments
  4. LATUDA $332 14 payments
  5. ARISTADA INITIO $293 6 payments
  6. ARISTADA Cns $293 6 payments
  7. ARISTADA Cns $293 6 payments
  8. ARISTADA Cns $293 6 payments
  9. ARISTADA Cns $293 6 payments
  10. Quillivant XR $264 13 payments
  11. Other $2,679 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

224 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record